Our innovative approach allows investment across the spectrum of women’s health indications and in technology infrastructure that supports new and innovative care delivery models.
“Investing in women’s health
is not a macro trend… It’s a global cultural shift.”
Our focused thesis is driven by our belief that women’s healthcare is a global market opportunity, in the nascent stage, that is primed for exponential growth driven by technological & business model innovation in established and new categories.
We invest across the spectrum of women’s health in medical devices, consumer health, digital health, new healthcare delivery models, ePharmacy and retail therapeutics.
